These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21905008)

  • 21. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.
    Nischalke HD; Berger C; Aldenhoff K; Thyssen L; Gentemann M; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U; Appenrodt B
    J Hepatol; 2011 Nov; 55(5):1010-6. PubMed ID: 21356257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria.
    Mockenhaupt FP; Cramer JP; Hamann L; Stegemann MS; Eckert J; Oh NR; Otchwemah RN; Dietz E; Ehrhardt S; Schröder NW; Bienzle U; Schumann RR
    J Commun Dis; 2006 Mar; 38(3):230-45. PubMed ID: 17373355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
    Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
    Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
    Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands.
    Terhorst D; Kalali BN; Weidinger S; Illig T; Novak N; Ring J; Ollert M; Mempel M
    Clin Exp Allergy; 2007 Mar; 37(3):381-90. PubMed ID: 17359388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis.
    Pehlivan Y; Gogebakan B; Oztuzcu S; Ozgen M; Cetin GY; Bayraktar R; Cengiz B; Kisacik B; Koca SS; Donmez S; Sayarlioglu M; Demiryurek AT; Onat AM
    J Rheumatol; 2012 Jan; 39(1):106-11. PubMed ID: 22045841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
    Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
    Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
    Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.
    Kawaguchi Y; Tochimoto A; Hara M; Kawamoto M; Sugiura T; Katsumata Y; Okada J; Kondo H; Okubo M; Kamatani N
    Arthritis Res Ther; 2006; 8(4):R104. PubMed ID: 16813666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis.
    Chang JH; Hampartzoumian T; Everett B; Lloyd A; McCluskey PJ; Wakefield D
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1711-7. PubMed ID: 17389503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the FAM167A-BLK region with systemic sclerosis.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.
    Veltkamp M; van Moorsel CH; Rijkers GT; Ruven HJ; Grutters JC
    Tissue Antigens; 2012 Jan; 79(1):25-32. PubMed ID: 22150367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.
    Veltkamp M; Wijnen PA; van Moorsel CH; Rijkers GT; Ruven HJ; Heron M; Bekers O; Claessen AM; Drent M; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2007 Sep; 149(3):453-62. PubMed ID: 17565608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population.
    Wipff J; Dieudé P; Guedj M; Ruiz B; Riemekasten G; Cracowski JL; Matucci-Cerinic M; Melchers I; Humbert M; Hachulla E; Airo P; Diot E; Hunzelmann N; Caramaschi P; Sibilia J; Valentini G; Tiev K; Girerd B; Mouthon L; Riccieri V; Carpentier PH; Distler J; Amoura Z; Tarner I; Degano B; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2010 Oct; 62(10):3093-100. PubMed ID: 20556823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease.
    Fatini C; Mannini L; Sticchi E; Rogai V; Guiducci S; Conforti ML; Cinelli M; Pignone AM; Bolli P; Abbate R; Cerinic MM
    Arthritis Rheum; 2006 Jul; 54(7):2263-70. PubMed ID: 16802365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.